Eysuvis, a new FDA-approved corticosteroid that is indicated for the short-term treatment, up to two weeks, of the signs and symptoms of dry eye disease. Patients often have periods of [&#8230;]

<description>Eysuvis, a new FDA-approved corticosteroid that is indicated for the short-term treatment, up to two weeks, of the signs and symptoms of dry eye disease. Patients often have periods of [&amp;#8230;]</description>

Eysuvis, a new FDA-approved corticosteroid that is indicated for the short-term treatment, up to two weeks, of the signs and symptoms of dry eye disease. Patients often have periods of 

Dry Eye Coach

Addressing Dry Eye Flares: Early Anecdotes and Experiences with Dr. Adam Ramsey

Addressing Dry Eye Flares: Early Anecdotes and Experiences with Dr. Adam Ramsey

Description